Control of progenitor cell number by mitogen supply and demand.
BACKGROUND
Much is known about how cell proliferation is controlled at the single cell level, but much less about the control of cell numbers in developing populations. Cell number might be determined by an intracellular division limiter or, alternatively, by the availability of mitogens or other factors outside the cell. We investigated the relative importance of intracellular and extracellular controls for one well-defined population of neural precursor cells, namely the glial progenitors that give rise to oligodendrocytes in the mouse spinal cord.


RESULTS
We found by cumulative BrdU labeling in vivo that the progenitor cell division cycle slows down markedly as their numbers increase during embryogenesis. When cultured in saturating PDGF, the main mitogen for these cells, their cell cycle accelerated and was independent of their prior rate of division in vivo. This shows that mitogens are limiting in vivo, and suggests that division normally slows down because the PDGF concentration declines. In PDGF-transgenic mice, cell number was proportional to the PDGF supply and apparently unsaturable; at ten times the normal rate of supply, cell number was still increasing but the animals were no longer viable.


CONCLUSIONS
Progenitor cell proliferation in the embryo is limited by environmental factors, not a cell-intrinsic mechanism. The linear relationship between PDGF supply and final cell number strongly suggests that cells deplete the mitogenic activity in their environment at a rate proportional to the total number of cells. The cells might simply consume the available PDGF or they might secrete autocrine inhibitors, or both.
van Heyningen
P
P
Wolfson Institute for Biomedical Research and Department of Biology, University College London, Gower Street, WC1E 6AE, London, UK.
Calver
A R
AR
Richardson
W D
WD
D000818:Animals; D002452:Cell Count; D002453:Cell Cycle; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005314:Embryonic and Fetal Development; D051379:Mice; D008934:Mitogens / Q000378:metabolism* / Q000494:pharmacology; D009836:Oligodendroglia / Q000166:cytology* / Q000187:drug effects; D010982:Platelet-Derived Growth Factor / Q000378:metabolism* / Q000494:pharmacology; D013116:Spinal Cord / Q000166:cytology; D013234:Stem Cells / Q000166:cytology* / Q000187:drug effects; D013997:Time Factors
D008934:Mitogens; D010982:Platelet-Derived Growth Factor